Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Bre... (iew in India. Bavituximab is in clinical...)

HOME >> MEDICINE >> NEWS

Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer

Date:11/16/2007

iew in India. Bavituximab is in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to the risk that the company will experience delays or difficulties in enrolling patients in the study, and the risk that the results from this trial will not be consistent with the results of prior trials or preclinical studies. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the e
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:

(Date:11/30/2009)...e cells than sedentary, healthy adults , , ...have shown that exercise can help ward off heart d... the reason why may be found within cells themselv... -- DNA at the tips of chromosomes that protect th... nonsmoking adults who did not exercise regularly,...

(Date:11/30/2009)...wswire-USNewswire/ -- SEIU Local 21LA members and ...dexo will hold a rally Tuesday, Dec. 1, 2009, at n...ers, 3800 Desire Parkway, New Orleans, to protest ...inary policies that target employees who are ill o...o employees who clean schools in the Recovery Scho...

(Date:11/30/2009)..., Nov. 30 A new poll released ... Foundation Center for Health Policy at the Univer...ia, shows a widespread consensus among the Latino/...care reform and indicates significant support for ...care tops the list of national issues identified b...

(Date:11/30/2009)... Nov. 30 Tyco Internatio...010 annual general meeting of shareholders will be...ntral European time at the Park Hyatt Zurich Hotel...Registered shareholders as of January 11, 2010 (th...ual general meeting. Additionally, individuals wh...

(Date:11/30/2009)... The launch of Invivo Corporation,s...irst FDA-cleared, fully-automated morphological sy...st of suspicious breast lesions. The ONCAD system ...ciety of North America 2009 Annual Meeting in Chic...xperts in breast MRI, ONCAD for DynaCAD uses a pat...

[0] Exercise Guards White Blood Cells Against Aging [1] As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness [1] New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option [1] Tyco International Sets Date for 2010 Annual General Meeting of Shareholders [0] New Breast MRI Technology Enables Enhanced Breast Cancer Detection

...mail Encryption business continues to drive perfor...ration (ZixCorp(R)), (Nasdaq: ZIXI ), the leader...-sponsored e-prescribing, today announced financia... the quarter, or $0.02 per share, compared with re...

...ARWICK, R.I., April 28 The Department of State to...izens avoid all nonessential travel to Mexico at t...ile the details of this global health concern cont...cgi-bin/prnh/20070529/NETU076LOGO ) , , "Right...

...UCLA scientists, in partnership with 30 research i...new gene variant that is highly common in autistic...tivity of the gene, known as CDH10, in the fetal b...n the advance online edition of the journal Natur...

...B 552 (Padilla) Designed to Educate First-Time Dri... Calif., April 28 Families of organ and tissue do...State Capitol on April 28 to urge lawmakers to pas...r or renew a driver,s license or ID card have the ...

...ealthcare interoperability and process management .... , , DENVER, April 28 MidTech Partners, Inc., a...OA Partner Advisory Council and the Microsoft BizT...e healthcare customers with SOA, interoperability ...

... Over half of physicians say there is a risk for a...ril 28 A new national study among 1,039 physician...orted that there is some level of risk that the Sw...was conducted by HCD Research and the Muhlenberg ...

Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu World's largest DNA scan for autism uncovers new gene variant for disorder Organ Donor Families, Transplant Recipients Journey to State Capitol to Urge Passage of Key Donor Designation Legislation MidTech Partners Ready for Microsoft BizTalk Server 2009 Swine Flu Outbreaks Cause Concern among U.S. Physicians

(Date:11/30/2009)..., , BLOOMFIELD HILLS, Mich., Nov. 30 /PRNew...ine shopping site dedicated exclusively to product... Savings Account (FSA/HSA) claims. The site is al...r-the-counter medications, saving shoppers up to 7...ealthSource helps cure two common healthcare heada...

(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNewswi...), the global authority on medical technology mark...cial injectable market declined by almost 5% over ...t as a result of the economic crisis. The market w... will return to the strong pre-recession growth ra...

(Date:11/30/2009)..., , CHICAGO, Nov. 30 Mi...cing more costly open surgery, particularly in onc... With a global market for image-guided navigation...s are embracing the advantages offered by minimall...ecovery times, greater patient comfort and faster ...

Breaking Medicine Technology:eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2 Facial Injectables Emerge From the Recession 2 Facial Injectables Emerge From the Recession 3 Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2 Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3 Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4 Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5 BioMarin to Present at the Morgan Stanley Healthcare Conference 13892 1 BioMarin to Present at the Morgan Stanley Healthcare Conference 13892 2 Will the FDA Ban Hydroquinone in Pigment Control Products 3F 56380 1 Will the FDA Ban Hydroquinone in Pigment Control Products 3F 56380 2 Will the FDA Ban Hydroquinone in Pigment Control Products 3F 56380 3 OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 1 OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 2 OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 3 OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 4 OneBeacon Professional Partners and Medversant Offer New Electronic Credentialing Solution to Managed Care Organizations 56375 5

[0] eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims [0] Facial Injectables Emerge From the Recession [0] Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures

... 18 ,Exelixis, Inc. (Nasdaq: EXEL ) today announc...xercise its option to license XL784 for further,de...ly announced that XL784,failed to meet its primary...etic nephropathy. Although the data in one subgrou...ting data being generated by other compounds,to wh...

...nic Stem Cell Lines for Therapeutic ...A California research team has,become the first to...f a,human embryo using donated oocytes (egg cells)...dy was published online today by the journal "Stem...prnh/20080117/CLTH022LOGO ), The experiments, us...

Other Medicine Technology:GSK Does Not Option XL784 for Further Development 2 GSK Does Not Option XL784 for Further Development 3 Study Reports Successful Cloning of Human Embryo Using Adult DNA 2 Study Reports Successful Cloning of Human Embryo Using Adult DNA 3

GSK Does Not Option XL784 for Further Development Study Reports Successful Cloning of Human Embryo Using Adult DNA

Fixed Core Curved Safe-T-J® Wire Guides - Standard (PTFE coated)

Amplatz Stiff Wire Guide

Fixed Core Straight Safety Wire Guides - Heavy Duty (PTFE coated)

Fixed Core Straight Safety Wire Guides - Standard (stainless steel)

Medicine Products:

Fixed Core Curved Safe-T-J® Wire Guides - Standard (PTFE coated)Amplatz Stiff Wire Guide Fixed Core Straight Safety Wire Guides - Heavy Duty (PTFE coated)Fixed Core Straight Safety Wire Guides - Standard (stainless steel)

Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Bre...(iew in India. Bavituximab is in clinical...),Health